Microbot Medical MBOT Net proceeds from sale of equity interest
Net proceeds from sale of equity interest at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromOtherEquity.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's net proceeds from sale of equity interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Microbot Medical's net proceeds from sale of equity interest?
- Microbot Medical (MBOT) reported net proceeds from sale of equity interest of $2.78B in Q4 2025.
- What does net proceeds from sale of equity interest mean?
- Represents the total cash inflows received from equity-related financing activities outside of standard common stock issuances. This metric captures capital raised through alternative instruments or private placements that bolster the company's liquidity position. It is a key indicator of the company's ability to secure non-dilutive or specialized equity funding to support long-term operations.